A carregar...

Fosaprepitant and aprepitant: an update of the evidence for their place in the prevention of chemotherapy-induced nausea and vomiting

INTRODUCTION: The selective neurokinin-1 receptor antagonist aprepitant is effective in the treatment of acute and delayed chemotherapy-induced nausea and vomiting (CINV) associated with both moderately and highly emetogenic chemotherapy. Fosaprepitant has been developed as an intravenous prodrug of...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Langford, Patrick, Chrisp, Paul
Formato: Artigo
Idioma:Inglês
Publicado em: Dove Medical Press 2010
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2963924/
https://ncbi.nlm.nih.gov/pubmed/21042544
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!